🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The IO/TKI regimens which combines Immune checkpoint inhibitors (IO) with T...
Status
Recruiting
Location
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University
Start Date
2026-05-06
Trial ID
NCT07571551
Treatments Being Tested
This study will evaluate the effect of investigational drugs, pembrolizumab...
Status
Recruiting
Location
Abramson Cancer Center at University of Pennsylvania
Start Date
2023-05-03
Trial ID
NCT05733715
Treatments Being Tested
This is a phase II prospective study to evaluate the safety and efficacy of...
Status
Completed
Location
Tianjin Medical University Cancer Institute & Hospital
Start Date
2023-04-24
Trial ID
NCT05807776
Treatments Being Tested
This is a parallel assigned, open-label, perspective trial studying the saf...
Status
Unknown
Location
Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University
Start Date
2022-05-20
Trial ID
NCT05339581
1. To compare systemic neoadjuvant therapy (combination of immune checkpoin...
Status
Unknown
Location
Institute of hepatobiliary surgery,Southwest Hospital
Start Date
2021-11-01
Trial ID
NCT05277675
Treatments Being Tested
The purpose of the study is to observe the effect of TACE/HAIC combined wit...
Status
Unknown
Location
Third Affiliated Hospital, Sun Yat-Sen University
Start Date
2022-05-30
Trial ID
NCT05250843
Treatments Being Tested
To evaluate the safety and efficacy of HAIC or Lenvatinib combined with Sin...
Status
Active Not Recruiting
Location
Tianjin Medical University Cancer Institute & Hospital
Start Date
2022-12-20
Trial ID
NCT05621499
Treatments Being Tested
Primary liver cancer is one of the most common malignant tumors in the worl...
Status
Recruiting
Location
Huapeng Sun
Start Date
2024-06-01
Trial ID
NCT06420440
Treatments Being Tested
In many cancers, early stage diagnosis and early treatment offers the best ...
Status
Withdrawn
Location
Melanoma Institute Australia
Start Date
2024-03
Trial ID
NCT05545969
Treatments Being Tested
This study will evaluate efficacy and safety of Toripalimab Injection (JS00...
Status
Terminated
Location
Fudan University Zhongshan Hospital
Start Date
2019-04-26
Trial ID
NCT03867370
Treatments Being Tested